GW Pharmaceuticals Overview
- Year Founded
-
1998
- Status
-
Acquired/Merged
- Employees
-
1,161
- Latest Deal Type
-
M&A
- Financing Rounds
-
12
GW Pharmaceuticals General Information
Description
Operator of a cannabinoid biopharmaceutical company focused on discovering, developing, and commercializing novel therapeutics. The company is focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform in a broad range of disease areas and is advancing an orphan drug program in the field of childhood epilepsy with a focus on Epidiolex (cannabidiol).
Contact Information
Website
www.gwpharm.co.ukCorporate Office
- Sovereign House
- Vision Park, Histon
- Cambridge CB24 9BZ
- England, United Kingdom
Corporate Office
- Sovereign House
- Vision Park, Histon
- Cambridge CB24 9BZ
- England, United Kingdom
GW Pharmaceuticals Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
GW Pharmaceuticals Comparisons
Industry
Financing
Details
GW Pharmaceuticals Competitors (7)
One of GW Pharmaceuticals’s 7 competitors is CNBX Pharmaceuticals, a Corporation company based in Bethesda, MD.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| CNBX Pharmaceuticals | Corporation | Bethesda, MD | ||||
| Ability Pharma | Private Equity-Backed | Cerdanyola, Spain | ||||
| CohBar | Formerly VC-backed | Menlo Park, CA | ||||
| PTC Therapeutics | Formerly VC-backed | Warren, NJ | ||||
| Ovid Therapeutics | Formerly VC-backed | New York, NY |
GW Pharmaceuticals Patents
GW Pharmaceuticals Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2005271060-A1 | Improved secure dispensing system | Inactive | 10-Aug-2004 | ||
| CA-2576126-A1 | Improved secure dispensing system | Inactive | 10-Aug-2004 | ||
| EP-1776670-A1 | Improved secure dispensing system | Inactive | 10-Aug-2004 | ||
| GB-0417793-D0 | Improved secure dispensing system | Inactive | 10-Aug-2004 | ||
| WO-2006016150-A1 | Improved secure dispensing system | Inactive | 10-Aug-2004 | B65D55/02 |
GW Pharmaceuticals Signals
GW Pharmaceuticals Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
GW Pharmaceuticals FAQs
-
When was GW Pharmaceuticals founded?
GW Pharmaceuticals was founded in 1998.
-
Where is GW Pharmaceuticals headquartered?
GW Pharmaceuticals is headquartered in Cambridge, United Kingdom.
-
What is the size of GW Pharmaceuticals?
GW Pharmaceuticals has 1,161 total employees.
-
What industry is GW Pharmaceuticals in?
GW Pharmaceuticals’s primary industry is Other Pharmaceuticals and Biotechnology.
-
Is GW Pharmaceuticals a private or public company?
GW Pharmaceuticals is a Private company.
-
What is the current valuation of GW Pharmaceuticals?
The current valuation of GW Pharmaceuticals is .
-
What is GW Pharmaceuticals’s current revenue?
The current revenue for GW Pharmaceuticals is .
-
How much funding has GW Pharmaceuticals raised over time?
GW Pharmaceuticals has raised $986M.
-
Who are GW Pharmaceuticals’s investors?
Capital Research and Management Company, Great Point Partners, M&G, Mentor Capital, and Prospect Investment Management are 5 of 9 investors who have invested in GW Pharmaceuticals.
-
Who are GW Pharmaceuticals’s competitors?
CNBX Pharmaceuticals, Ability Pharma, CohBar, PTC Therapeutics, and Ovid Therapeutics are some of the 7 competitors of GW Pharmaceuticals.
-
When was GW Pharmaceuticals acquired?
GW Pharmaceuticals was acquired on 05-May-2021.
-
Who acquired GW Pharmaceuticals?
GW Pharmaceuticals was acquired by Jazz Pharmaceuticals.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process